Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302763297> ?p ?o ?g. }
- W4302763297 endingPage "142" @default.
- W4302763297 startingPage "132" @default.
- W4302763297 abstract "Background Individuals in violent intimate relationships are at a high risk of sustaining both orthopaedic fractures and traumatic brain injury (TBI), and the fracture clinic may be the first place that concurrent intimate partner violence (IPV) and TBI are recognized. Both IPV and TBI can affect all aspects of fracture management, but prevalence of TBI and comorbid TBI and IPV is unknown. Questions/purposes (1) What are the previous-year and lifetime prevalence of IPV and TBI in women presenting to an outpatient orthopaedic fracture clinic? (2) What are the conditional probabilities of TBI in the presence of IPV and the reverse, to explore whether screening for one condition could effectively identify patients with the other? (3) Do patients with TBI, IPV, or both have worse neurobehavioral symptoms than patients without TBI and IPV? Methods The study was completed in the fracture clinic at a community Level 1 trauma center in Southern Ontario from July 2018 to March 2019 and included patients seen by three orthopaedic surgeons. Inclusion criteria were self-identification as a woman, age 18 years or older, and the ability to complete forms in English without assistance from the person who brought them to the clinic (for participant safety and privacy). We invited 263 women to participate: 22 were ineligible (for example, they were patients of a surgeon who was not on the study protocol), 87 declined before hearing the topic of the study, and data from eight were excluded because the data were incomplete or lost. Complete data were obtained from 146 participants. Participants’ mean age was 52 ± 16 years, and the most common diagnosis was upper or lower limb fracture. Prevalence of IPV was calculated as the number of women who answered “sometimes” or “often” to direct questions from the Woman Abuse Screening Tool, which asks about physical, emotional, and sexual abuse in the past year or person’s lifetime. The prevalence of TBI was calculated as the number of women who reported at least one head or neck injury that resulted in feeling dazed or confused or in loss of consciousness lasting 30 minutes or less on the Ohio State University Traumatic Brain Injury Identification Method, a standardized procedure for eliciting lifetime history of TBI through a 3- to 5-minute structured interview. Conditional probabilities were calculated using a Bayesian analysis. Neurobehavioral symptoms were characterized using the Neurobehavioral Symptom Inventory, a standard self-report measure of everyday emotional, somatic, and cognitive complaints after TBI, with total scores compared across groups using a one-way ANOVA. Results Previous-year prevalence of physical IPV was 7% (10 of 146), and lifetime prevalence was 28% (41 of 146). Previous-year prevalence of TBI was 8% (12 of 146), and lifetime prevalence was 49% (72 of 146). The probability of TBI in the presence of IPV was 0.77, and probability of IPV in the presence of TBI was 0.36. Thus, screening for IPV identified proportionately more patients with TBI than screening for TBI, but the reverse was not true. Neurobehavioral Symptom Inventory scores were higher (more symptoms) in patients with TBI only (23 ± 16) than those with fractures only (12 ± 11, mean difference 11 [95% CI 8 to 18]; p < 0.001), in those with IPV only (17 ± 11) versus fractures only (mean difference 5 [95% CI -1 to -11]; p < 0.05), and in those with both TBI and IPV (25 ± 14) than with fractures only (mean difference 13 [95% CI 8 to 18]; p < 0.001) or those with IPV alone (17 ± 11, mean difference 8 [95% CI -1 to 16]; p < 0.05). Conclusion Using a brief screening interview, we identified a high self-reported prevalence of TBI and IPV alone, consistent with previous studies, and a novel finding of high comorbidity of IPV and TBI. Given that the fracture clinic may be the first healthcare contact for women with IPV and TBI, especially mild TBI associated with IPV, we recommend educating frontline staff on how to identify IPV and TBI as well as implementing brief screening and referral and universal design modifications that support effective, efficient, and accurate communication patients with TBI-related cognitive and communication challenges. Level of Evidence Level II, prognostic study." @default.
- W4302763297 created "2022-10-07" @default.
- W4302763297 creator A5007905915 @default.
- W4302763297 creator A5031541824 @default.
- W4302763297 creator A5047906621 @default.
- W4302763297 creator A5048125439 @default.
- W4302763297 creator A5068492485 @default.
- W4302763297 creator A5080468957 @default.
- W4302763297 creator A5084333425 @default.
- W4302763297 creator A5089391263 @default.
- W4302763297 date "2022-10-06" @default.
- W4302763297 modified "2023-09-30" @default.
- W4302763297 title "What Is the Prevalence of Intimate Partner Violence and Traumatic Brain Injury in Fracture Clinic Patients?" @default.
- W4302763297 cites W1535379795 @default.
- W4302763297 cites W1902120928 @default.
- W4302763297 cites W1988521268 @default.
- W4302763297 cites W1991970837 @default.
- W4302763297 cites W1992018833 @default.
- W4302763297 cites W2031504469 @default.
- W4302763297 cites W2035445406 @default.
- W4302763297 cites W2036683236 @default.
- W4302763297 cites W2036796994 @default.
- W4302763297 cites W2100187987 @default.
- W4302763297 cites W2100240119 @default.
- W4302763297 cites W2107592884 @default.
- W4302763297 cites W2111279030 @default.
- W4302763297 cites W2123663428 @default.
- W4302763297 cites W2124601126 @default.
- W4302763297 cites W2145315443 @default.
- W4302763297 cites W2167919085 @default.
- W4302763297 cites W2275430691 @default.
- W4302763297 cites W2399661739 @default.
- W4302763297 cites W2513404541 @default.
- W4302763297 cites W2607227165 @default.
- W4302763297 cites W2609210487 @default.
- W4302763297 cites W2765289325 @default.
- W4302763297 cites W2806176415 @default.
- W4302763297 cites W2807949861 @default.
- W4302763297 cites W2897349735 @default.
- W4302763297 cites W2898631319 @default.
- W4302763297 cites W2919241137 @default.
- W4302763297 cites W2922749486 @default.
- W4302763297 cites W2946598100 @default.
- W4302763297 cites W3095813720 @default.
- W4302763297 cites W3107246748 @default.
- W4302763297 cites W3129399448 @default.
- W4302763297 cites W3155051333 @default.
- W4302763297 cites W3166658278 @default.
- W4302763297 cites W3194136363 @default.
- W4302763297 cites W2957125599 @default.
- W4302763297 doi "https://doi.org/10.1097/corr.0000000000002329" @default.
- W4302763297 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36200843" @default.
- W4302763297 hasPublicationYear "2022" @default.
- W4302763297 type Work @default.
- W4302763297 citedByCount "3" @default.
- W4302763297 countsByYear W43027632972022 @default.
- W4302763297 countsByYear W43027632972023 @default.
- W4302763297 crossrefType "journal-article" @default.
- W4302763297 hasAuthorship W4302763297A5007905915 @default.
- W4302763297 hasAuthorship W4302763297A5031541824 @default.
- W4302763297 hasAuthorship W4302763297A5047906621 @default.
- W4302763297 hasAuthorship W4302763297A5048125439 @default.
- W4302763297 hasAuthorship W4302763297A5068492485 @default.
- W4302763297 hasAuthorship W4302763297A5080468957 @default.
- W4302763297 hasAuthorship W4302763297A5084333425 @default.
- W4302763297 hasAuthorship W4302763297A5089391263 @default.
- W4302763297 hasConcept C118552586 @default.
- W4302763297 hasConcept C126322002 @default.
- W4302763297 hasConcept C141071460 @default.
- W4302763297 hasConcept C142724271 @default.
- W4302763297 hasConcept C167135981 @default.
- W4302763297 hasConcept C1862650 @default.
- W4302763297 hasConcept C187155963 @default.
- W4302763297 hasConcept C190385971 @default.
- W4302763297 hasConcept C2780110798 @default.
- W4302763297 hasConcept C2780724011 @default.
- W4302763297 hasConcept C2781017439 @default.
- W4302763297 hasConcept C3017944768 @default.
- W4302763297 hasConcept C3020110884 @default.
- W4302763297 hasConcept C526869908 @default.
- W4302763297 hasConcept C542059537 @default.
- W4302763297 hasConcept C545542383 @default.
- W4302763297 hasConcept C71924100 @default.
- W4302763297 hasConceptScore W4302763297C118552586 @default.
- W4302763297 hasConceptScore W4302763297C126322002 @default.
- W4302763297 hasConceptScore W4302763297C141071460 @default.
- W4302763297 hasConceptScore W4302763297C142724271 @default.
- W4302763297 hasConceptScore W4302763297C167135981 @default.
- W4302763297 hasConceptScore W4302763297C1862650 @default.
- W4302763297 hasConceptScore W4302763297C187155963 @default.
- W4302763297 hasConceptScore W4302763297C190385971 @default.
- W4302763297 hasConceptScore W4302763297C2780110798 @default.
- W4302763297 hasConceptScore W4302763297C2780724011 @default.
- W4302763297 hasConceptScore W4302763297C2781017439 @default.
- W4302763297 hasConceptScore W4302763297C3017944768 @default.
- W4302763297 hasConceptScore W4302763297C3020110884 @default.
- W4302763297 hasConceptScore W4302763297C526869908 @default.
- W4302763297 hasConceptScore W4302763297C542059537 @default.